GlaxoSmithKline’s decision to change the way it promotes its products and compensates its employees could change the drug business forever.
For this story and more tune in tonight.
Hosts
Top Stories from CNBC- Trump slams Biden, teases 2024 presidential run in first post White House speech
- Dow futures surge more than 300 points as the 10-year Treasury yield declines
- Warren Buffett owns more of a Chinese electric car company than General Motors
- CDC director signs off on J&J's single-shot Covid vaccine, clearing way for distribution to begin
- UK hunts for missing person infected with Covid variant first detected in Brazil
